Orient Pharma Co., Ltd.
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.oppharma.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
4
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- Conditions
- Primary HypercholesterolemiaMixed Dyslipidemias
- Interventions
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT04643093
- Locations
- 🇦🇺
Paratus Clinical Research Western Sydney, Blacktown, Australia
🇦🇺Northern Beaches Clinical Research, Brookvale, Australia
🇦🇺Emeritus Research, Camberwell, Australia
Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: ORADUR®-Methylphenidate
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT02704390
- Locations
- 🇨🇳
Chang Gung Medical Foundation- Chiayi Branch, Chiayi City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Chang Gung Medical Foundation- Linkuo Branch, Taoyuan, Taiwan
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
- Conditions
- Pulmonary Tuberculosis
- Interventions
- Drug: HRZE
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 557
- Registration Number
- NCT02467608
- Locations
- 🇨🇳
Changhua Christian Hospital, Changhua, Taiwan
🇨🇳Changhua Hosiptal Ministry of Health And Welfare, Changhua, Taiwan
🇨🇳Chang Gung Memorial Hospital, ChiaYi, Chiayi City, Taiwan
Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: ORADUR® First, then PlaceboDrug: Placebo First, then ORADUR®
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2021-12-06
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 114
- Registration Number
- NCT02450890
- Locations
- 🇨🇳
Chang Gung Medical Foundation- Chiayi Branch, Chiayi City, Taiwan
🇨🇳Tri-Service General Hospital, Taipei City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 202
- Registration Number
- NCT01710007
- Locations
- 🇨🇳
Buddhist Taipei TzuChi General Hospital, New Taipei City, Taiwan
🇨🇳Cardinal Tien Hospital, New Taipei City, Taiwan
🇨🇳Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan
- Prev
- 1
- 2
- Next